Product Pipeline for Insulin-Requiring Diabetes Treatments
ViaCyte on Twitter: "Nov. 6: ViaCyte VP, Research and CSO Kevin D'Amour to speak at @ISSCR's “From Stem Cell Biology to New Therapies” https://t.co/f8anGrT6wi #ISSCR #biotech #Toronto #health #T1D #type1diabetes #diabetes #regenerativemedicine #
Diabetes Device Engineering | Implanting Cell Replacement Therapies
ViaCyte | Regenerative Medicine Therapies for Diabetes
JDRF Reports: First-in-Human Gene-Edited Stem Cell Trial? Check.
Diabetes Device Engineering | Implanting Cell Replacement Therapies
ViaCyte (@ViaCyte) / Twitter
ViaCyte Acquires Rights to BetaLogics Assets
Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials - Senior - 2019 - Diabetic Medicine - Wiley Online Library
First Patient Dosed in Phase 1 Clinical Trial for T1D | The Stem Cellar
Pin on Diabetes
Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials - Senior - 2019 - Diabetic Medicine - Wiley Online Library
CRISPR and ViaCyte dose first subject in Phase I T1D therapy trial
ViaCyte Announces Second Clinical Trial Site at University of Alberta
Frontiers | Stem Cell-Based Clinical Trials for Diabetes Mellitus | Endocrinology
Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient - The Niche
ViaCyte (@ViaCyte) / Twitter
Breakthrough Technologies for Cell Replacement Therapies for Diabetes| ViaCyte
Product Pipeline for Insulin-Requiring Diabetes Treatments
Brendan Smith on LinkedIn: Today, CRISPR Therapeutics and ViaCyte announced that Health Canada
JDRF Partner ViaCyte to Immediately Initiate Type 1 Diabetes Clinical Trial — Juicebox Podcast and Arden's Day
ViaCyte's Future 'Functional Diabetes Cure' for Diabetes
CIRM-supported Type I Diabetes treatment enters clinical trials in Europe | The Stem Cellar
CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)
